Michael Eging is named as a lobbyist on federal disclosure filings for 1 client through Reata Pharmaceuticals. The most recent filing naming them posted in October 2012. Issues reported include Health Issues.
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| REATA PHARMACEUTICALS | REATA PHARMACEUTICALS | Q3 2012 | Health Issues |
| Year | Clients | Registrants |
|---|---|---|
| 2012 | 1 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Michael Eging. See the Capitol Clarity rankings and method.